These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12738113

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Severe antiretroviral-associated skin reactions in South African patients: a case series and case-control analysis.
    Stewart A, Lehloenya R, Boulle A, de Waal R, Maartens G, Cohen K.
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1313-1319. PubMed ID: 27464823
    [Abstract] [Full Text] [Related]

  • 24. Rash, hepatotoxicity and hyperbilirubinemia among Kenyan infants born to HIV-infected women receiving triple-antiretroviral drugs for the prevention of mother-to-child HIV transmission.
    Minniear TD, Zeh C, Polle N, Masaba R, Peters PJ, Oyaro B, Akoth B, Ndivo R, Angira F, Mills LA, Thomas TK.
    Pediatr Infect Dis J; 2012 Nov; 31(11):1155-7. PubMed ID: 22772167
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK, Panel on Clinical Practices for Treatment of HIV.
    Ann Intern Med; 2002 Sep 03; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [Abstract] [Full Text] [Related]

  • 27. Nevirapine-induced hepatitis: a case series and review of the literature.
    Piliero PJ, Purdy B.
    AIDS Read; 2001 Jul 03; 11(7):379-82. PubMed ID: 11494710
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
    Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB.
    AIDS; 1999 Mar 11; 13(4):479-86. PubMed ID: 10197376
    [Abstract] [Full Text] [Related]

  • 30. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Jan 05; 49(51-52):1153-6. PubMed ID: 11198946
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Rash and hepatitis within days of starting a new antiretroviral regimen: nevirapine hypersensitivity, secondary syphilis or both?
    Saxon CJ, Helbert MR, Komolafe AJ, Higgins SP.
    Int J STD AIDS; 2014 Mar 05; 25(3):228-30. PubMed ID: 23970648
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Severe eye complications from toxic epidermal necrolysis following initiation of Nevirapine based HAART regimen in a child with HIV infection: a case from Cameroon.
    Tchetnya X, Ngwasiri CA, Munge T, Aminde LN.
    BMC Pediatr; 2018 Mar 13; 18(1):108. PubMed ID: 29534693
    [Abstract] [Full Text] [Related]

  • 36. Case series of acute hepatitis in a non-selected group of HIV-infected patients on nevirapine-containing antiretroviral treatment.
    de Maat MM, ter Heine R, van Gorp EC, Mulder JW, Mairuhu AT, Beijnen JH.
    AIDS; 2003 Oct 17; 17(15):2209-14. PubMed ID: 14523278
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Hepatotoxicity in healthy infants exposed to nevirapine during pregnancy].
    Iveli P, Noguera-Julian A, Soler-Palacín P, Martín-Nalda A, Rovira-Girabal N, Fortuny-Guasch C, Figueras-Nadal C.
    Enferm Infecc Microbiol Clin; 2016 Jan 17; 34(1):39-44. PubMed ID: 25487604
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Oral adverse effects due to the use of Nevirapine.
    Moura MD, Senna MI, Madureira DF, Fonseca LM, Mesquita RA.
    J Contemp Dent Pract; 2008 Jan 01; 9(1):84-90. PubMed ID: 18176653
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.